13D Filings
EYENOVIA, INC.
HYPD
Amendment
Ownership

9.99%

Total Shares

435,438

Issuer CIK

1682639

CUSIP

30234E203

Event Date

Jun 10, 2025

Accepted

Jun 13, 2025, 02:54 PM

Reporting Persons (8)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Avenue Capital Management II, L.P.
Investment Adviser
9.99%435,438435,4380
Marc Lasry
Individual
9.99%435,43800
Avenue Venture Opportunities Partners II, LLC
Other
5.99%261,26300
Avenue Venture Opportunities Fund II, L.P.
Other
5.99%261,26300
GL Venture Opportunities Partners II, LLC
Other
5.99%261,26300
GL Venture Opportunities Partners, LLC
Other
4.00%174,17500
Avenue Venture Opportunities Partners, LLC
Other
4.00%174,17500
Avenue Venture Opportunities Fund, L.P.
Other
4.00%174,17500
Disclosure Items (7)

Security Title

COMMON STOCK, par value $0.0001 per share

Issuer Name

EYENOVIA, INC.

Issuer Address

23461 South Pointe Drive, Laguna Hills, CA, 92653

Filing Persons

The information set forth in Item 2(a) of the Schedule 13D is incorporated by reference. The Reporting Persons expressly disclaim status as a "group" for purposes of this Amendment. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to the Schedule 13D as Exhibit 99.1 thereto. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Amendment except to the extent of such Reporting Person's pecuniary interest, if any, therein.

Business Address

The information set forth in Item 2(b) of the Schedule 13D is incorporated by reference.

Principal Occupation

The information set forth in Item 2(c) of the Schedule 13D is incorporated by reference.

Convictions

The information set forth in Item 2(e) of the Schedule 13D is incorporated by reference.

Citizenship

The information set forth in Item 2(f) of the Schedule 13D is incorporated by reference.

The information set forth in Item 3 of the Schedule 13D is incorporated herein by reference.

(a) - (c) On June 11, 2025, Fund and Fund II converted an aggregate of $680,098 of the original aggregate Principal of $10 million of that certain Capital Growth Loan (the "Loan") provided to Issuer pursuant to a Loan and Security Agreement, and related agreements (collectively, the "Agreement"), entered into by and among Issuer, as borrower, Fund and Fund II, as lenders, and Manager, as administrative agent and collateral agent. Such conversion resulted in the issuance of an aggregate of 404,820 shares of Common Stock to the Funds and reduced the principal balance of the Loan to $9,319,902. Pursuant to the Third Amendment to the Supplement, beneficial ownership of Common Stock by the Reporting Persons is limited to the Blocker (as defined below). Following the conversion, each of Fund and Fund II directly owns the percentage of Common Stock shown in row 13 of its respective cover page, and collectively, the Reporting Persons own 9.99% of Issuer's Common Stock. See also Item 5. Other than entering into the Agreement and the transaction reported herein, Reporting Persons have not engaged in any transaction with respect to the shares of Issuer's Common Stock. The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Common Stock in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as they may deem appropriate in light of the circumstances existing from time to time, which may include disposal of some or all of the shares of Common Stock currently owned by the Reporting Persons or otherwise acquired by them pursuant to conversion of debt or in privately negotiated transactions. Any such transactions may be effected at any time or from time to time subject to any applicable limitations imposed on the sale of the Common Stock by applicable law. Except to the extent the foregoing may be deemed a plan or proposal, the Reporting Persons have no additional plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.

Percentage of Class

See Items 7-11 and Item 13 of the cover page for each Reporting Person. Pursuant to the terms of the Third Amendment to the Supplement, the Reporting Persons cannot convert any portion of their loans to the extent the Reporting Persons would beneficially own, in the aggregate, after any such conversion, more than 9.99% of the outstanding shares of Common Stock of the Issuer (the "Blocker"). Consequently, as of the date reported herein, the Reporting Persons are not able to fully convert the Loan due to the Blocker. The Blocker of 9.99% may be changed to up to 19.99% at the Reporting Persons' election upon at least 61 days' notice to the Issuer.

Number of Shares

See Items 7 through 11 of the cover page for each Reporting Person.

Transactions

Not applicable.

Shareholders

The information set for in Item 5(d) of the Schedule 13D is incorporated by reference.

Date of 5% Ownership

See Item 4.

The information set forth in Item 6 of the Schedule 13D is incorporated herein by reference.

Exhibit 99.1: Joint Filing Agreement by and among the Reporting Persons (filed as Exhibit 99.1 to Schedule 13D on May 15, 2025). https://www.sec.gov/Archives/edgar/data/1682639/000182912625003724/avenueventure_ex99-1.htm

EYENOVIA, INC. — Schedule 13D | 13D Filings